Trial Profile
A Phase II multi-dose efficacy study of BnoX (buprenorphine) for moderate to severe pain
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 13 Feb 2018
Price :
$35
*
At a glance
- Drugs Buprenorphine (Primary)
- Indications Pain
- Focus Therapeutic Use
- 13 Feb 2018 New trial record
- 08 Feb 2018 According to an iX Biopharma media release, this trial is currently ongoing.